Kaiser Permanente receives $3 million CDC grant to continue SEARCH study for childhood diabetes

The Kaiser Permanente Southern California Department of Research & Evaluation has been awarded more than $3 million from the Centers for Disease Control and Prevention to continue the SEARCH for Diabetes in Youth Study for an additional five years to 2015. SEARCH is a multi-center observational study that is nationally recognized as the largest and most ethnically diverse study of youth with type 1 and type 2 diabetes ever conducted in the United States. The combined population under surveillance for childhood diabetes across the five centers is just under 5 million youth.

"Although diabetes mellitus is one of the most common chronic diseases of childhood, we had limited data before the SEARCH study began to evaluate not only the temporal trends in the diagnosis of type 1 and type 2 diabetes, but also the complications, quality of life, and quality of care received by children with diabetes from diverse backgrounds," said Jean M. Lawrence, ScD, MPH, MSSA, research scientist with the Department of Research & Evaluation, Kaiser Permanente Southern California, and the study's principal investigator for the California clinical center.

The SEARCH study began in 2000 and was designed to better understand the apparent increase of type 2 diabetes in youth within several populations -- especially American Indians, Hispanics, and African Americans -- and to learn whether the increase in the incidence of type 1 observed in other countries was also occurring in the U.S. Within Kaiser Permanente Southern California's membership, more than 200 children are newly diagnosed with diabetes each year.

"The SEARCH study's unique ability to gather information from around the United States has led to important findings about the prevalence of type 1 and type 2 diabetes in childhood as well as the risk factors that may be associated with future complications," said Joshua Allen May, MD, pediatric endocrinologist, at Kaiser Permanente's Los Angeles Medical Center. "The study highlights the increasing problem of type 2 diabetes in youth and will continue to contribute greatly to our current understanding of pediatric diabetes due to the size of the population being studied as well as the geographic and ethnic diversity of the study participants."

"Due to the racial and ethnic diversity of the Kaiser Permanente membership that mirrors that of the Southern California population, and our significant scientific contributions to this study over the past 10 years, the funding from the CDC enables us to continue to conduct the SEARCH study," notes Dr. Lawrence. "SEARCH is a part of the growing body of knowledge about children with diabetes in this country."

Co-investigators on the California study team include Kristi Reynolds, PhD, MPH from the Department of Research & Evaluation; Ann Kershnar, MD, a pediatric endocrinologist with the Southern California Permanente Medical Group; and David Pettitt, MD, of the Sansum Diabetes Research Institute in Santa Barbara, California.

In addition to the Kaiser Permanente Southern California clinical center, the SEARCH for Diabetes in Youth Study has four other clinical centers located at the Cincinnati Children's Hospital Medical Center, the University of Colorado in Denver, Seattle Children's Research Institute, and the University of North Carolina at Chapel Hill. The coordinating center is at Wake Forest University and the central laboratory is at the University of Washington.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes